CALR mutations screening in wild type JAK2V617F and MPLW515K/L Brazilian myeloproliferative neoplasm patients-Reference-Cited by-同舟云学术

CALR mutations screening in wild type JAK2V617F and MPLW515K/L Brazilian myeloproliferative neoplasm patients

Published:2015-10 Issue:3 Volume:55 Page:236-240
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Nunes Daniela Prudente Teixeira,de Lima Luciene Terezina,Chauffaille Maria de Lourdes,Mitne-Neto Miguel,dos Santos Marcos Tadeu,Cliquet Marcelo Gil,Guerra-Shinohara Elvira Maria

Funder

FAPESP

CNPq

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference47 articles.

1. Another piece of the myeloproliferative neoplasms puzzle;Levine;N. Engl. J. Med.,2013

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature,2005

3. A gain-of-function mutation of JAK2 in myeloproliferative disorders;Kralovics;N. Engl. J. Med.,2005

4. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis;Levine;Cancer Cell,2005

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms;Colombia Medica;2023-12-19

2. Calreticulin: a quintessential multifaceted protein with therapeutic potential;Journal of Proteins and Proteomics;2023-06-26

3. Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm;Galen Medical Journal;2021-12-07

4. Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms;Hematology, Transfusion and Cell Therapy;2020-07

5. Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms;Seminars in Hematology;2018-10